Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Click here to view this article.

Related Videos
Experts on inflammatory bowel disease.
Experts on inflammatory bowel disease.
Victor Kim, MD: Addressing Comorbidities and Advancing COPD Care
Victor-Kim-MD
Related Content

Nalbuphine ER Tablets Show Promise as Cough Therapy in Patients with IPF

May 31st 2023

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

May 26th 2023

JP Llanos Ackert, MD, C Ambrose, MD: New Data Support Tezepelumab for Asthma

May 31st 2023

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

May 26th 2023

Stress Leads to Increased Risk of Depression, Anxiety for Psoriasis Patients

May 31st 2023

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

May 31st 2023

Nalbuphine ER Tablets Show Promise as Cough Therapy in Patients with IPF

May 31st 2023

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

May 26th 2023

JP Llanos Ackert, MD, C Ambrose, MD: New Data Support Tezepelumab for Asthma

May 31st 2023

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

May 26th 2023

Stress Leads to Increased Risk of Depression, Anxiety for Psoriasis Patients

May 31st 2023

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

May 31st 2023

Nalbuphine ER Tablets Show Promise as Cough Therapy in Patients with IPF

May 31st 2023

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

May 26th 2023

JP Llanos Ackert, MD, C Ambrose, MD: New Data Support Tezepelumab for Asthma

May 31st 2023

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

May 26th 2023

Stress Leads to Increased Risk of Depression, Anxiety for Psoriasis Patients

May 31st 2023

Upadacitinib Demonstrates Significant Improvements in Disease Activity, Flare in SLE

May 31st 2023
© 2023 MJH Life Sciences

All rights reserved.